Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Apr 2024 | |
Neoplasms | Preclinical | CN | 01 Apr 2024 | |
Neoplasms | Preclinical | CN | 01 Apr 2024 |